2025, Number 1
Meet the editor: Iván Pérez-Neri
Language: English
References: 0
Page: 8-9
PDF size: 148.77 Kb.
I am a Chemist and Doctor of Science from the Universidad Nacional Autónoma de México (UNAM), and I have devoted my professional life to unraveling the complexities of neurochemistry and disability research. My journey in science and academia has been one of curiosity, perseverance, and a commitment to creating impactful change, both within the scientific community and in public health.
My academic foundation was laid at UNAM, where I obtained a degree in Pharmaceutical and Biological Chemistry, followed by a Doctorate in Biomedical Science. These formative years instilled in me a profound respect for scientific rigor and interdisciplinary collaboration. My professional tenure as a Medical Sciences Researcher at the National Institute of Neurology and Neurosurgery Manuel Velasco Suárez has been a cornerstone of my career. There, I contributed significantly to the Laboratory of Neurochemistry, exploring intricate biochemical pathways and their relevance to neurological disorders. Currently, I coordinate the Evidence Synthesis Unit at the National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra in Mexico. As a level II member of the National System of Researchers in Mexico, I continue to uphold the highest standards of research and innovation.
Throughout my career, I have authored 66 publications, a scientific book, and six book chapters, accumulating 806 citations on Scopus with an h-index of 14. These works traverse the realms of basic and clinical research, addressing critical topics such as neurodegeneration, psychiatric disorders, and neurotransmitter systems.
Mentorship has been one of the most gratifying aspects of my professional life. Guiding 18 medical specialty students and a Master's student to achieve their academic aspirations has reinforced my belief in the transformative power of education. Beyond academia, my research has been showcased at over 50 national and international conferences, earning eight prestigious awards for excellence in basic and clinical research. These accolades reflect a career steeped in dedication and the pursuit of scientific breakthroughs.
In 2019, I had the honor of participating in technical panels at the Mexican Senate, contributing to discussions on public health policies related to cannabis regulation. This opportunity underscored the importance of bridging scientific expertise with policymaking to address pressing societal issues. As an educator, I have designed and taught courses for medical residency programs, aiming to empower future healthcare professionals with the tools they need to excel. My participation in developing evidence synthesis methodologies within a global collaborative network exemplifies my commitment to advancing both science and education.
Editorial responsibilities have also been a significant part of my professional contributions. As the former Editor-in-Chief of "Archivos de Neurociencias" and the current Editor-in-Chief of "Investigación en Discapacidad", I am entrusted with fostering the dissemination of high-quality research. Additionally, I serve as an Academic Editor for the Neurology section of Annals of Medicine. These roles have allowed me to amplify the voices of researchers and ensure the global impact of their findings, particularly in neurology and disability studies.
My affiliations with esteemed organizations such as the Cochrane Collaboration, the Association for Interdisciplinary Meta-research and Open Science, and the SPOR Evidence Alliance underscore my dedication to interdisciplinary approaches and evidence-based practices. My involvement in the development of methodological guidelines, such as the InSynQ checklist, further highlights my expertise and commitment to advancing research quality.
Looking ahead, I remain committed to fostering innovation and collaboration in neurochemistry and disability research. By continuing to mentor the next generation of researchers, contribute to impactful policies, and engage with the broader scientific community, I aim to expand the frontiers of knowledge and drive meaningful improvements in public health and patient care worldwide.
With a steadfast focus on bridging the gap between scientific discovery and real-world application, I aspire to influence future advancements that address both complex medical challenges and the broader dimensions of disability. This vision drives my ongoing efforts to collaborate across disciplines, inspire transformative education, and advocate for inclusive public health initiatives.
Artificial intelligence declaration: this manuscript was elaborated entirely using ChatGPT 4o (OpenAI). The author revised and corrected the text and takes full responsibility for its content.
AFFILIATIONS
1 Evidence Synthesis Unit. National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra.
CORRESPONDENCE
Iván Pérez-Neri. E-mail: ipneri03@gmail.com